Soligenix (NASDAQ: SNGX ) stock is rocketing higher on Tuesday following positive data from the late-stage biopharmaceutical company’s extended HyBryte treatment . This data interim data comes from a 12-month study testing HyBryte as a treatment for early-stage cutaneous T-cell lymphoma (CTCL). Six patients have been enrolled in the study with four of them having completed at least 12 weeks of treatment.
Of those four patients, three of them have already achieved treatment success. This is measured as a 50% improvement in their cumulative mCAILS score compared to baseline. The fourth patient has seen significant improvement over 18 weeks: How This Affects SNGX Stock With this news comes heavy trading of SNGX shares as investors buy the stock.
That has more than 46 million shares changing hands as of this writing. This is well above its daily average trading volume of about 222,000 shares. SNGX stock is up 296% as of Tuesday morning.
Investors will want to keep reading for more of the most recent stock market stories! We have all of the hottest stock market news ready to go on Tuesday! Among that is what has shares of Corning (NYSE: GLW ), Helen Of Troy (NASDAQ: HELE ) and Indivior (NASDAQ: INDV ) stock moving today. All of this news is ready to go at the following links! More Tuesday Stock Market News Corning (GLW) Stock Shimmers After Earnings. How Did It Become the Next AI Play? Why Is Helen Of Troy (HELE) Stock Down 25% Today? Why Is Indivior (INDV) Stock Down 37% Today?.
